This is one of the achievements we are most proud of.

FIGHT KIDS CANCER is a joint initiative by KickCancer, Imagine for Margo (France) and the Fondatioun Kriibskrank Kanner (Luxembourg), the aim of which is to accelerate the most innovative treatments thanks to European financing and collaboration of research on paediatric cancers. FIGHT KIDS CANCER entails the launch of recurring annual calls for projects. Since 2020 we have committed a total of 6.53 million euros, of which 1.6 million euros are funded by KickCancer.

In October 2021, we launched our third FIGHT KIDS CANCER call for projects for a total amount of 4 million euros of which KickCancer will finance 1 million euros.

In Belgium, France, Luxembourg and Italy, as well as in other European countries in the future, those projects are financed thanks to the organisation of our charity family races. When more runners participate or their motivation to fundraise increases, the amount we can invest in research follows suit.

Participate in RUN TO KICK 2022 by running, walking or donating to one of your friends that participate or by sponsoring us and shooting kids’ cancer forever away!

In 2021, our second call led to the selection, by independent international experts, of 5 innovative research projects of European scope for a total amount of 3,45 million euros of which KickCancer finance 800 000 €. Through these projects, we hope to foster improvements in the knowledge and treatment of the following diseases:

In 2020, the first call led to the selection of six innovative projects

for a total amount of 3,08 million euros, from which 800 000 € were financed by KickCancer. These 6 projects are about the following diseases: high-grade gliomas (2 projects : n°1 & n°2), acute myeloid leukaemia’s, rhabdoid tumours, osteosarcoma and neuroblastomas.


  • Financed: 6.53 M€ since 2020 (+ 4 M€ committed in 2022)
    More than 85% of your donations go to financing research and supporting our advocacy work, less than 15% go to administration.
  • Duration: 3 years
  • Countries: Europe
  • Disease: All malignancies
  • Status: Ongoing

Other Projects